The kidney is an important organ for controlling the volume of body fluids, electrolytic balance and excretion/reabsorption of endogenous and exogenous compounds. Among these renal functions, excretion/reabsorption of endogenous and exogenous substance is very important for the maintenance of physiological homeostasis in the body. Recently discovered organic anion transporters (OAT or SLC22A) have important roles for renal functions. It is well known as drug transporter. Several isoforms belong to SLC22A family. They showed different transport substrate spectrums and different localizations within the kidney. Their gene expressions are changed by some stimulus. The functional transport properties are regulated by protein kinase C. In addition, the function of organic anion transporters are also regulated by protein-protein interaction, such as caveolin which is compositional protein of caveolae structure. In this review, we will give an introduction of organic anion transporters and its regulatory mechanisms.
Introduction of Organic Anion Transporters (SLC22A) and a Regulatory Mechanism by Caveolins

Introduction
The kidney, as well as the liver, plays a primary role in the excretion of endogenous/exogenous compounds and their metabolites [1] [2] [3] [4] [5] . In addition to glomerular filtration, the kidney excretes charged compounds via carrier-mediated pathways, which are organic anion transport pathways, in renal proximal tubular cells [6] [7] [8] [9] .
Particularly the organic anion transport pathway has been shown to mediate the elimination of various drugs including anti-human immunodeficiency virus therapeutics, non-steroidal anti-inflammatory drugs, antitumor drugs, antibiotics, diuretics, and antihypertensives 10) . These compounds are chemically heterogeneous substances possessing a carbon backbone and This renal excretion is closely related to physiological events occurring in nephrons, i.e., filtration, secretion, and reabsorption.
More than 80 years ago, it was already observed that phenolsulfonphthalein, an organic anion, was highly concentrated in the renal convoluted tubules, indicative of the tubular secretion process 11) . 10, 14) . OAT1 and ROAT1 are identical and will be collectively referred to as OAT1. OAT1 is a 551-amino-acid protein with 12 putative transmembrane domains (Fig. 1 ). nuated by the existence of phorbol-ester, a protein kinase C activator 17, 18) . In addition, the putative phosphorylation sites for protein kinase A, casein knase II, and tyrosine kinase have also been reported. Whether any of these sites is used for the regulation of OATs is as yet unclarified.
All OATs have several N-glycosylation sites between the first and second transmembrane domains.
Inhibition of glycosylation by tunicamycin in mouse OAT1-expressing COS-7 cells resulted in an increase of intracellular accumulation of newly synthesized transporters, suggesting that glycosylation is required for insertion of OAT1 into the plasma membrane 19) . generates the sodium ion gradient between the plasma membrane 21) , and the electrochemical gradient of the sodium ions derives the transport of dicarboxylates via the Na ＋ -dicarboxylate cotransporter (a secondary active transporter) 22) . Using the gradient of dicarboxylates, the PAH transporter takes up organic anions in exchange for the dicarboxylates (a tertiary active transporter). In addition to this classical PAH transporter, an additional uptake system has been characterized employing bulky organic anion fluoresceinmethotrexate as a substrate 23) . Uptake of fluoresceinmethotrexate is independent of Na ＋ and is not inhibited by PAH or glutarate. The molecular identity of this transporter has not yet been established.
Molecular identification and
tissue distribution of OATs
OAT1
The transport properties of OAT1 has been characterized functionally using Xenopus oocytes and the cell expression system ( Table 2 ). The cloned OAT1 has been expressed in Xenopus laevis oocytes 10, [14] [15] [16] [24] [25] [26] , COS-7 cells 19) , or HeLa cells 16) . The uptake ratio of radiolabeled PAH in cells expressing these carriers was increased compared with that water-injected oocytes or mock-transfected cells, respectively. The 16, 25) ; 37 µM for mOAT1 19) ; 14 and 70 µM for rOAT1 10, 14) and 21 µM for flounder OAT1 27) ).
Uptake of PAH by rOAT1, hOAT1, and fOAT1 was trans-stimulated by intracellulary accumulated α-ketoglutarate or glutarate. Similarly, efflux of radiolabeled glutarate from OAT1-expressing oocytes was trans-stimulated by PAH in the incubation medium 28) . 10, 15, [28] [29] [30] [31] . The affinities of these compounds for OAT1 were very similar to those reported for those of the basolateral PAH transporter. In addition, the hydrophobicity and the strength of the anionic charge of substrates appear to be closely related to their affinity for OAT1 32) . OAT1 also transports ochratoxin A 33) that is well known as the etiologic agent responsible for Balkan nephropathy.
When OAT1-overexpressing cells and mock-transfected cells were exposed to ochratoxin A, decreased cell viability was observed in OAT1-expressing cells, which were recovered by inhibition of the OAT1-mediated uptake of ochratoxin A. This result suggests that OAT1 is associated with proximal tubular damage caused by anionic toxicants 33, 34) .
Recently, an electrophysiological approach was used to demonstrate translocation of organic anions by fOAT1-expressing Xenopus oocytes 35) . PAH, etacrynic acid, bumetanide, and tienilic acid evoked an inward current. In contrast to these compounds, probenecid and furosemide did not generate an inward current.
The tissue distribution of cloned rat, mouse, and human OAT1 is investigated by northern blot analysis (Table 2) 10, 14-16, 19, 25, 26) . rOAT1, mOAT1, and hOAT1 mRNAs are expressed predominantly in the kidney and very weakly in the brain. In the rat kidney, rOAT1 is localized in the middle portion of proximal tubules (S2 segment) as determined by in situ hybridization 10) .
Immunohistochemical localization also demonstrated the rat 36, 37) and human OAT1 25) proteins are restricted to the S2 segment of proximal tubular cells. Western blot analysis revealed that the rOAT1-encoded protein size was about 77 kDa. This rOAT1 protein was up-regulated by infusion of chronic furoemide or hydrochlorothiazide 38) .
OAT2
OAT2 has cloned by the membrane protein previously called the novel liver transporter (NLT), but whose transport substrates had not been identified 39) .
Rat OAT2 had 42% amino acid sequence homology with rOAT1, and was shown to be a member of the OAT family (Table 1) 40)
. rOAT2 mediated the sodiumindependent transport of salicylate (Km=88 µM) and α -ketoglutarate (Km=18 µM). rOAT2 also mediated the transport of PGE2, methotrexate, acetylsalicylate, and PAH ( 41) . Mouse OAT2 was isolated and characterized in 2002 42) . Different from rOAT2, mOAT2 is 540-amino-acid protein having 88% homology with rOAT2. Gene expression of mOAT2 was quite different from that of rOAT2. In contrast to rOAT2 mRNA was expressed predominantly in liver, mOAT2 mRNA was not detected in liver with Northern blot analysis. This mOAT2 mRNA was weakly detected in female liver but not kidney. In substrate specificity, mOAT2 mediated the sodium-independent transport of glutarate (Km=15.8 µM) and PGE2 (Km=5.2 µM).
Interestingly, no transport of salicylate, prototype substrate of rOAT2, was detected. The gene expression of rOAT2 in isolated hepatocytes were down-regulated by the treatment with nitric oxide 43) .
OAT3
Rat OAT3, another member of the multispecific organic anion transporter family, was isolated from the rat brain by the RT-PCR cloning method based on the sequence conserved among rOAT1, rOAT2, rOAT5 and mOAT6 44) . rOAT3 shows 49, 39, 37 and 48% identity with rOAT1, rOAT2, rOAT5 and mOAT6, respectively ( . This newly cloned hOAT3 transported estrone sulfate (Km=3.2 µM), PAH (Km=87.2 µM), methotrexate (Km=10.9 µM), cimetidine (Km=57.4 µM), dehydroepiandrosterone sulfate, estradiol glucuronide, glutarate, PGE2 and so on. The difference of these two clone was that the amino acid sequences of C-terminus of newly identified hOAT3 was shorter than those of old hOAT3. rOAT3 mRNA was expressed in the liver, kidney and brain, and a weak expression was detected in the eye. hOAT3 mRNA was detected mainly in the kidney and very weakly in the brain and smooth muscle.
The distribution of hOAT3 protein was observed at the basolateral membrane of proximal tubule cells
OAT4
Recently, we identified the fourth member of organic anion transporter expressed in the human placenta using EST (expressed sequence tag) database searched for "query OAT1" 47) . OAT4 is a 551- amino-acid protein with 12 putative membranespanning domains. hOAT4 showed 38 to 44% identity with those of other members of the OAT family (Table   1 ). When expressed in Xenopus oocytes, OAT4 mediated the high-affinity transport of estrone sulfate (Km=1.01 µM) and dehydroepiandrosterone sulfate (Km=0.63 µM) in a sodium-independent manner (Table 2 ). OAT4 also mediated the transport of ochratoxin A and PAH. OAT4-mediated transport of estrone sulfate was inhibited by several sulfate conjugates, such as p-nitrophenyl sulfate, α-naphthyl sulfate, β-estradiol sulfate, and 4-methylumbelliferyl sulfate. In contrast, glucuronide conjugate showed little or no inhibitory effect on the OAT4-mediated transport of estrone sulfate. Recent report has shown that the transport mode of hOAT4 was also organic anion/ dicarboxylate exchagner 48) . Northern blot analysis revealed that OAT4 mRNA is abundantly expressed in the placenta as well as in the kidney. OAT4 is the first member of the multispecific organic anion transporter family that is expressed abundantly in the placenta.
OAT4 might be responsible for the elimination and detoxification of harmful anionic substances from the fetus.
OAT5
fifth member of OAT (OAT5) was recently identified by Youngblood and Sweet from mouse kidney 12) . In 2001, human OAT5 have reported as hOAT4 by Sun et al. 49) . It was confirmed additionally as a renal steroid sulfate conjugate transporter 50) . The rat ortholog also reported in 2005 51) . also transported those substrate with sodium independently. The protein of OAT5 was localized at the apical membrane of renal proximal tubules.
OAT6
The sixth member of OAT was recently identified from murine olfactory mucosa 13) . Based on sequence homology proposed to be an organic anion transporter;
OAT6. However, they did not show any functional evidence. In this year, Schnabolk and coworkers have reported functional properties of OAT6 using X. laevis oocytes and transfected CHO cells 52) . A) The kidneys were lysed using a teflon/glass homogenizer and a sonicator, and subjected to sucrose gradient centrifugation as described under Materials and Methods. B) Cell lysates were immuno-precipitated initially with antibodies of rOAT3 or Cav-1 and the respective immuno-precipitated proteins were loaded onto each lane of a 10% SDS-polyacrylamide gel. Kidney lysate was immuno-precipitated initially with rOA3 (left pannel) and was immuno-precipitated initially with Cav-1 antibodies (right pannel). shown that several transporter proteins including pglycoprotein 53) , cationic amino acid transporter 54) , glucose transporter 55) , and sodium-calcium exchanger (Fig. 4) . When the rOAT1 and rOAT3 cRNA were expressed with antisense oligodeoxynucleotide of caveolins, the transport ability of rOAT1 or rOAT3 was decreased (Fig. 5) . These results show that functional properties was regulated by scaffolding protein as well as protein kinase C.
Conclusion
The past few years have witnessed great advances in our knowledge of the molecular pharmacology of renal organic anion transport. The organic anion transport system is also important as a drug or xenobiotics transport system. The techniques for molecular biology enabled us to obtain much information about the identity of the organic anion transporters. 
